Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Clinical Microbiology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Bacteriology

Simple Microdilution Test for Detection of Metallo-β-Lactamase Production in Pseudomonas aeruginosa

Roberta Migliavacca, Jean-Denis Docquier, Claudia Mugnaioli, Gianfranco Amicosante, Rossana Daturi, Kyungwon Lee, Gian Maria Rossolini, Laura Pagani
Roberta Migliavacca
1Dipartimento di Scienze Morfologiche, Eidologiche e Cliniche, Sez. di Microbiologia, Università di Pavia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jean-Denis Docquier
2Dipartimento di Biologia Molecolare, Sez. di Microbiologia, Università di Siena, 53100 Siena
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Claudia Mugnaioli
2Dipartimento di Biologia Molecolare, Sez. di Microbiologia, Università di Siena, 53100 Siena
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gianfranco Amicosante
3Dipartimento di Scienze e Tecnologie Biomediche, Università di L'Aquila, 67100 L'Aquila, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rossana Daturi
4Servizio di Analisi Microbiologiche, I.R.C.C.S. S. Matteo, 27100 Pavia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kyungwon Lee
5Department of Clinical Pathology and Research Institute of Bacterial Resistance, Yonsei University College of Medicine, Seoul, Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gian Maria Rossolini
2Dipartimento di Biologia Molecolare, Sez. di Microbiologia, Università di Siena, 53100 Siena
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laura Pagani
1Dipartimento di Scienze Morfologiche, Eidologiche e Cliniche, Sez. di Microbiologia, Università di Pavia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: lpagani@unipv.it
DOI: 10.1128/JCM.40.11.4388-4390.2002
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

A microdilution test measuring imipenem MICs in the presence or absence of a mixture of EDTA plus 1,10-phenanthroline was developed and tested on 190 Pseudomonas aeruginosa isolates, including 18 VIM- and 4 IMP-type metallo-β-lactamase (MBL) producers. The chelator mixture reduced by fourfold or more the imipenem MICs for MBL producers, while a lower effect or no effect was usually observed with MBL nonproducers.

Acquired metallo-β-lactamases (MBLs) of the IMP or VIM type, encoded by integron-borne mobile gene cassettes, have started spreading worldwide as a cause of broad-spectrum β-lactam resistance in Pseudomonas aeruginosa and other gram-negative nosocomial pathogens (2, 10). Resistance mediated by MBLs is not overcome by conventional β-lactamase inhibitors (2, 10). For this reason, MBLs are presently included among the resistance determinants of increasing clinical importance (2, 10) and their monitoring has become an important issue in clinical microbiology. Although certain resistance phenotypes might be suggestive of acquired MBL production in isolates of naturally susceptible species, production of these enzymes is not readily detectable by conventional susceptibility testing and must be confirmed by enzyme assays and molecular detection of the corresponding genes. To facilitate the screening for MBL producers in the clinical microbiology laboratory, phenotypic tests based on the principle of disk diffusion for rapid detection of MBL-producing isolates have recently been proposed (1, 7).

In this work, we developed a new test, based on a simple microdilution technique, for phenotypic detection of MBL-producing P. aeruginosa. The test was named the EPI (after EDTA-phenanthroline-imipenem) microdilution test.

Bacterial strains.

The strains used in this study included 188 nonreplicate clinical isolates of P. aeruginosa and the reference P. aeruginosa strains PAO1 (12) and ATCC 27853. Clinical isolates were from various geographic areas and hospitals and included 22 MBL producers (producing either IMP- or VIM-type enzymes) and 166 MBL nonproducers. MBL producers included some strains that have already been described, namely, 101/1477 (5), VR-143/97 (6), VR-193/98 (15), VA-182/00 (3), and NTU-26/99 (17), and additional clinical isolates in which MBL production was confirmed by enzyme assays (6), and the nature of the MBL determinant was identified by PCR analysis. Detection and identification of blaVIM genes were carried out as described previously (3). Detection and identification of blaIMP genes were carried out by amplification of a 361-bp internal region of blaIMP genes (from nucleotides 2168 to 2528; GenBank accession no. AF416297 ) and analysis of the AluI restriction pattern of the amplicon. PCR amplification was carried out, using the IMP-DIA primers (IMP-DIA/f, 5′-ggAATAgAgTggCTTAATTCTC; IMP-DIA/r, 5′-gTgATgCgTCYCCAAYTTCACT), in a 50-μl volume containing 50 pmol of each primer, 200 μM deoxynucleoside triphosphates, 10 ng of genomic DNA of the test strain, and 3.5 U of the Expand high fidelity PCR system (Roche Biochemicals, Mannheim, Germany), in the reaction buffer provided by the manufacturer, under the following cycling parameter conditions: initial denaturation at 94°C for 240 s; denaturation at 94°C for 60 s, annealing at 52°C for 60 s, and extension at 72°C for 90 s, repeated for 25 cycles; and final extension at 72°C for 600 s. All of the MBL nonproducers were confirmed to lack blaIMP- or blaVIM-related sequences by colony blot hybridization using a blaIMP-1 probe and a blaVIM-1 probe (16). All the MBL producers and most of the nonproducers were resistant to imipenem, ceftazidime and cefepime. Twelve of the MBL producers were known to produce the PER-1 extended-spectrum β-lactamase (11; L. Pagani, unpublished results). Twenty-six of the imipenem-resistant isolates not producing MBL activity were known to be deficient in the OprD protein, as detected by sodium dodecyl sulfate-polyacrylamide gel electrophoresis of outer membrane protein extracts (9). Thirty-four of the imipenem-resistant isolates not producing MBL activity were known to constitutively produce the AmpC enzyme, as revealed by isoelectric focusing analysis of crude extracts (9). OprD loss, constitutive AmpC production, and PER-1 production were investigated in some but not all of the isolates. Identification of isolates was carried out according to standard procedures (4). Susceptibility testing was carried out by disk diffusion and interpreted according to the guidelines of the National Committee for Clinical Laboratory Standards (14).

EPI microdilution test.

The EPI microdilution test was carried out as follows. Imipenem MICs were determined with a standard microdilution assay (13) in 96-well microtiter plates (Greiner Labortechnik GmbH, Kremsmünster, Austria), using Mueller-Hinton broth (Difco Laboratories, Detroit, Mich.) and a bacterial inoculum of 5 × 104 CFU per well, in a final volume of 100 μl. Imipenem concentrations in the range of 512 to 0.25 μg/ml were tested. The MICs were determined either in the absence or in the presence of a mixture of EDTA plus 1,10-phenanthroline. The final concentrations of the chelators to be used in the test were selected on the basis of the results of preliminary experiments in which the inhibition of MBL activity and the toxicity of variable concentrations of the chelators were tested with a subset of 20 randomly selected isolates, including 10 MBL producers (2 producing IMP-type and 8 producing VIM-type enzymes) and 10 MBL nonproducers (randomly selected from imipenem-resistant isolates). These experiments revealed the following: (i) the growth of the tested strains was not significantly inhibited by a final EDTA concentration of up to 0.4 mM; (ii) at a fixed EDTA concentration of 0.4 mM, the growth of the tested strains was not significantly inhibited by a final 1,10-phenanthroline concentration of up to 0.04 mM, while at a 0.2 mM 1,10-phenanthroline concentration, toxicity was observed with some strains; and (iii) the best results in terms of comparative MIC reduction were observed using final concentrations of EDTA and 1,10-phenanthroline of 0.4 and 0.04 mM, respectively, and these final concentrations were used in the test. The mixture of divalent ion chelators was added (at a 2× final concentration) to the bacterial suspension just before inoculation of the wells. A growth control in the presence of the chelators mixture was always included. Results were recorded by visual inspection of microtiter plates after 18 h of incubation at 37°C. The tests were conducted in a blinded study by a person who did not know which were the MBL producers. All tests were performed in triplicate, with highly reproducible results. Within each series, the imipenem and the imipenem-plus-chelators MICs were identical or differed by 1 twofold dilution at most. In different experiments, the MIC ratio reduction caused by the presence of the chelators remained constant or differed for a few MBL nonproducers by twofold at most. In the latter cases, the highest ratios were used for comparisons. Chemicals were from Sigma Chemical Co. (St. Louis, Mo.). Media and chemicals of the same lot number were used.

Detection of MBL producers by the EPI microdilution test.

Using the EPI microdilution test, all the P. aeruginosa isolates which produced an acquired MBL exhibited a notable reduction of imipenem MICs in the presence of the mixture of chelators. The magnitude of reduction ranged from 4- to 512-fold (median, 32-fold). In 19 of 22 (86%) cases, the reduction was equal to or higher than 32-fold. The lowest reductions were observed with two of the IMP-2 producers and with one of the VIM-2 producers (Table 1). Under the same conditions, isolates that did not produce acquired MBLs usually exhibited no reduction or a twofold reduction of imipenem MICs, while only a minority of them showed a fourfold reduction or, in one case, an eightfold reduction (Table 1). In particular, imipenem resistance sustained by mechanisms other than MBL production was not significantly influenced by the presence of chelators.

View this table:
  • View inline
  • View popup
TABLE 1.

Results of the EPI test carried out with 190 P. aeruginosa strains

With a minimum fourfold imipenem MIC reduction designated as the cutoff value for detection of MBL producers, the EPI test could detect all the isolates which produced an acquired MBL (95% confidence interval [CI], 81.5 to 100%), with 3% of the results false positives (CI, 1.1 to 7.2%). With a minimum eightfold imipenem MIC reduction designated as the cutoff value, the test detected 95% of the MBL producers (CI, 75.1 to 99.8%), with 0.6% false positives (CI, 0 to 3.8%). Finally, with a minimum 16-fold imipenem MIC reduction designated as the cutoff value, the test detected 86% of the MBL producers (CI, 64 to 96.4%), with no false positives (CI, 0 to 2.8%). It should be noted that the only MBL producer to exhibit a fourfold MIC reduction exhibited an imipenem MIC (128 μg/ml) greater than those observed with nonproducers showing the same MIC reduction (64 to 16 μg/ml).

Concluding remarks.

The development of simple screening tests that are designed for the detection of acquired MBL production and that are suitable for routine use in the clinical microbiology laboratory is a critical step toward large-scale monitoring of these emerging resistance determinants in various clinical settings. Such tests will eventually be useful for the design of containment measures and for verification of their efficacy. A similar approach would be particularly useful for P. aeruginosa, in which carbapenem resistance is often caused by mechanisms other than acquired MBLs, such as decreased permeability of the outer membrane and/or active efflux, possibly associated to overproduction of the endogenous class C β-lactamase (8). Although phenotypic tests based on disk diffusion have already been described for that purpose (1, 7), they are not suitable for automation and must rely upon analogical interpretation. The EPI microdilution test described in this paper appears to be a simple, specific, and sensitive method for the screening of acquired MBL production in P. aeruginosa. Compared with the tests based on disk diffusion, in which identification of MBL producers must rely upon the evaluation of changes in the appearance of growth inhibitory zones in proximity to a disk containing an inhibitor (1, 7), the EPI microdilution test should allow better standardization in recording results and might also be amenable to automation.

ACKNOWLEDGMENTS

This work was supported in part by a grant from Bio-Merieux Italia S.p.a. and by a grant from M.I.U.R. (no. 2001068755_003).

Thanks are due to Francesco Luzzaro for providing us with some of the MBL-producing clinical isolates and to Jing-Jou Yan for providing us with the P. aeruginosa NTU-26/99 VIM-3-producing strain.

FOOTNOTES

    • Received 4 March 2002.
    • Returned for modification 3 April 2002.
    • Accepted 29 August 2002.
  • Copyright © 2002 American Society for Microbiology

REFERENCES

  1. 1.↵
    Arakawa, Y., N. Shibata, K. Shibayama, H. Kurukawa, T. Yagi, H. Fujiwara, and M. Goto. 2000. Convenient test for screening metallo-β-lactamase-producing gram-negative bacteria by using thiol compounds. J. Clin. Microbiol.38:40-43.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    Bush, K. 1999. β-Lactamases of increasing clinical importance. Curr. Pharm. Des.11:839-845.
    OpenUrl
  3. 3.↵
    Docquier, J. D., F. Luzzaro, G. Amicosante, A. Toniolo, and G. M. Rossolini. 2001. Multidrug-resistant Pseudomonas aeruginosa producing PER-1 extended-spectrum serine-β-lactamase and VIM-2 metallo-β-lactamase. Emerg. Infect. Dis.7:910-911.
    OpenUrlCrossRefPubMedWeb of Science
  4. 4.↵
    Kiska, D. L., and P. H. Gilligan. 1999. Pseudomonas, p. 517-525. In P. M. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 7th ed. ASM Press, Washington, D.C.
  5. 5.↵
    Laraki, N., M. Galleni, I. Thamm, M. L. Riccio, G. Amicosante, J. M. Frère, and G. M. Rossolini. 1999. Structure of In31, a blaIMP-containing Pseudomonas aeruginosa integron phyletically related to In5, which carries an unusual array of gene cassettes. Antimicrob. Agents Chemother.43:890-901.
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    Lauretti, L., M. L. Riccio, A. Mazzariol, G. Cornaglia, G. Amicosante, R. Fontana, and G. M. Rossolini. 1999. Cloning and characterization of blaVIM, a new integron-borne metallo-β-lactamase gene from a Pseudomonas aeruginosa clinical isolate. Antimicrob. Agents Chemother.43:1584-1590.
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    Lee, K., Y. Chong, H. B. Shin, Y. A. Kim, D. Yong, and J. H. Yum. 2001. Modified Hodge and EDTA-disk synergy tests to screen metallo-β-lactamase-producing strains of Pseudomonas and Acinetobacter species. Clin. Microbiol. Infect.7:88-91.
    OpenUrlCrossRefPubMedWeb of Science
  8. 8.↵
    Livermore, D. M. 2001. Of Pseudomonas, porins, pumps and carbapenems. J. Antimicrob. Chemother.47:247-250.
    OpenUrlCrossRefPubMedWeb of Science
  9. 9.↵
    Livermore, D. M., and J. D. Williams. 1996. β-Lactams: mode of action and mechanisms of bacterial resistance, p. 502-578. In V. Lorian (ed.), Antibiotics in laboratory medicine, 4th ed. Williams & Wilkins, Baltimore, Md.
  10. 10.↵
    Livermore, D. M., and N. Woodford. 2000. Carbapenemases: a problem in waiting? Curr. Opin. Microbiol.5:489-495.
    OpenUrl
  11. 11.↵
    Luzzaro, F., E. Mantengoli, M. Perilli, G. Lombardi, V. Orlandi, A. Orsatti, G. Amicosante, G. M. Rossolini, and A. Toniolo. 2001. Dynamics of a nosocomial outbreak of multidrug-resistant Pseudomonas aeruginosa producing the PER-1 extended-spectrum β-lactamase. J. Clin. Microbiol.39:1865-1870.
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    Moulton, R. C., and R. C. Montie. 1979. Chemotaxis by Pseudomonas aeruginosa. J. Bacteriol.137:274-280.
    OpenUrlAbstract/FREE Full Text
  13. 13.↵
    National Committee for Clinical Laboratory Standards. 2000. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A5. National Committee for Clinical Laboratory Standards, Wayne, Pa.
  14. 14.↵
    National Committee for Clinical Laboratory Standards. 2000. Performance standards for antimicrobial disk susceptibility tests. Approved standard M2-A7. National Committee for Clinical Laboratory Standards, Wayne, Pa.
  15. 15.↵
    Pallecchi, L., M. L. Riccio, J. D. Docquier, R. Fontana, and G. M. Rossolini. 2001. Molecular heterogeneity of blaVIM-2-containing integrons from Pseudomonas aeruginosa plasmids encoding the VIM-2 metallo-β-lactamase. FEMS Microbiol. Lett.195:145-150.
    OpenUrlPubMedWeb of Science
  16. 16.↵
    Rossolini, G. M., M. L. Riccio, G. Cornaglia, L. Pagani, C. Lagatolla, L. Selan, and R. Fontana. 2000. Carbapenem-resistant Pseudomonas aeruginosa with acquired blaVIM metallo-β-lactamase determinants, Italy. Emerg. Infect. Dis.6:312-313.
    OpenUrlCrossRefPubMed
  17. 17.↵
    Yan, J.-J., P.-R. Hsueh, W.-C. Ko, K.-T. Luh, S.-H. Tsai, H.-M. Wu, and J.-J. Wu. 2001. Metallo-β-lactamases in clinical Pseudomonas isolates in Taiwan and identification of VIM-3, a novel variant of the VIM-2 enzyme. Antimicrob. Agents Chemother.45:2224-2228.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top
Download PDF
Citation Tools
Simple Microdilution Test for Detection of Metallo-β-Lactamase Production in Pseudomonas aeruginosa
Roberta Migliavacca, Jean-Denis Docquier, Claudia Mugnaioli, Gianfranco Amicosante, Rossana Daturi, Kyungwon Lee, Gian Maria Rossolini, Laura Pagani
Journal of Clinical Microbiology Nov 2002, 40 (11) 4388-4390; DOI: 10.1128/JCM.40.11.4388-4390.2002

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Clinical Microbiology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Simple Microdilution Test for Detection of Metallo-β-Lactamase Production in Pseudomonas aeruginosa
(Your Name) has forwarded a page to you from Journal of Clinical Microbiology
(Your Name) thought you would be interested in this article in Journal of Clinical Microbiology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Simple Microdilution Test for Detection of Metallo-β-Lactamase Production in Pseudomonas aeruginosa
Roberta Migliavacca, Jean-Denis Docquier, Claudia Mugnaioli, Gianfranco Amicosante, Rossana Daturi, Kyungwon Lee, Gian Maria Rossolini, Laura Pagani
Journal of Clinical Microbiology Nov 2002, 40 (11) 4388-4390; DOI: 10.1128/JCM.40.11.4388-4390.2002
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • Bacterial strains.
    • EPI microdilution test.
    • Detection of MBL producers by the EPI microdilution test.
    • Concluding remarks.
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Anti-Bacterial Agents
imipenem
Pseudomonas aeruginosa
beta-lactamases

Related Articles

Cited By...

About

  • About JCM
  • Editor in Chief
  • Board of Editors
  • Editor Conflicts of Interest
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Resources for Clinical Microbiologists
  • Ethics
  • Contact Us

Follow #JClinMicro

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

 

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0095-1137; Online ISSN: 1098-660X